PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Rheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, 45110, Ioannina, Greece.\', \'Laboratory Medicine, Department of Microbiology, Medical School, University of Ioannina, 45110, Ioannina, Greece.\', \'Gastroenterology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, 45110, Ioannina, Greece.\', \'Rheumatology Clinic, Department of Internal Medicine, Medical School, University of Ioannina, 45110, Ioannina, Greece. adrosos@uoi.gr.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s00296-021-04818-2
?:hasPublicationType
?:journal
  • Rheumatology international
is ?:pmid of
?:pmid
?:pmid
  • 33655421
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.906
?:rankingScore_hIndex
  • 62
is ?:relation_isRelatedTo_publication of
?:title
  • Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33655421>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33655421>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all